35 percent of patients with breast cancer worried about genetic risks to themselves, family members
the ONA take:
According to a new study conducted at the University of Michigan Comprehensive Cancer Center in Ann Arbor, Michigan, researchers have found that a third of women diagnosed with breast cancer are concerned about the genetic risk of a family member developing cancer or developing other cancers themselves.
For the study, researchers surveyed 1,536 women who had been treated for breast cancer that were included in the Surveillance, Epidemiology and End Results (SEER) databases.
Results showed that 35% of women with breast cancer expressed a strong desire for genetic testing, while 43% did not have a discussion about genetic testing with a health care professional.
The study also found that racial minority participants were less likely than white patients to discuss genetic testing with a health care professional despite a strong desire to do so.
Researchers found that many patients, particularly Latinas who spoke only Spanish, were concerned that their loved ones might get breast cancer in the future due to inherited risk.
Study results were published in the Journal of Clinical Oncology.
A third of women diagnosed with breast cancer are concerned about the genetic risk of a family member developing cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
- Colorectal Cancer Screening Rate Increased by Digital Self-Ordering
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|